Opportunities for unpartnered assets

Steven Muntner, vice president of deals at Informa Pharma Intelligence, discusses key takeaways from a recent report looking at pharma partnering and deal trends. On the sidelines of the 2016 BIO-Europe partnering meeting, he also highlights the biggest opportunities for unpartnered assets and recent changes in the partnering landscape.

Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Steven Muntner – VP/Head of Deals, Pharma Intelligence, Informa